Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Haloperidol and Placebo in Bipolar I Mania
NCT00129220Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2005
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of olanzapine in bipolar I disorder (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Young Mania Rating Scale at 3 weeks. Started Jul 2005; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00129220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129220.